Resources

Study Coordination

Latest Study Coordination Resources

Strategic Patient Screening Q&A – Pre-Screening Process Related

Beth Harper of Clinical Performance Partners answers questions related to the pre-screening process asked in her webinar, Strategic Patient Screening.

Read more

Strategic Patient Screening Q&A – Feasibility & Budgets

Beth Harper of Clinical Performance Partners answers study feasibility and recruitment budget questions asked in her webinar, Strategic Patient Screening.

Read more

What Should be Included in the Informed Consent Form?

Ashley Smith shares what information should be included in the Informed Consent Form (ICF) to ensure clinical trial participants are fully informed.

Read more

Conducting Clinical Research? Address Your Needs & Wants Effectively

There are several things one needs to do to conduct research. However, there are also several wants. Learn how to address them both with a CTMS.

Read more

How Paper and Electronic Source Data Meet ALCOA Elements

According to the FDA, data should meet certain fundamental elements of quality (ALCOA), whether they’re recorded on paper or electronically.

Read more

Is a Patient’s Last Impression More Important Than Their First?

The final interaction a clinical trial participant has with a study should leave a lasting impression, but too often these opportunities are missed.

Read more

Free Online Courses for Learning Clinical Trial Basics

These classes provide opportunities to learn about clinical research fundamentals.

Read more

Informed Consent: How do You Assess a Patient’s Understanding?

Beth Harper of Clinical Performance Partners answers this question and more from a popular webinar presentation on informed consent.

Read more

Clinical Trials are a Learning and Teaching Opportunity

As researchers, our mission is to learn, as well as teach our patients. Consider these tips when teaching patients during informed consent.

Read more

Managing Multi-Center Trials — Q&A (Part 2)

Representatives from Harvard/Dana-Farber answer more questions about conducting trials within its consortium, as well as with unaffiliated sites.

Read more

1 8 9 10 11